Together, these data indicated that TIGIT and PD-1 might play a synergistic role in tumor immune and inflammatory response to promote the development of a severe dysfunctional phenotype in T cells in breast cancer as reported in other cancers [27,30]. Here, TIGIT is linked to breast carcinoma.